TrialAsia-Pacific journal of clinical oncology2021

Bevacizumab plus cisplatin/pemetrexed then bevacizumab alone for unresectable malignant pleural mesothelioma: A Japanese safety study.

Takashi Nakano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.